Cargando…

Optimising a person-centred approach to stopping medicines in older people with multimorbidity and polypharmacy using the DExTruS framework: a realist review

BACKGROUND: Tackling problematic polypharmacy requires tailoring the use of medicines to individual circumstances and may involve the process of deprescribing. Deprescribing can cause anxiety and concern for clinicians and patients. Tailoring medication decisions often entails beyond protocol decisi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Turk, Amadea, Wong, Geoffrey, Mahtani, Kamal R., Madden, Michelle, Hill, Ruaraidh, Ranson, Ed, Wallace, Emma, Krska, Janet, Mangin, Dee, Byng, Richard, Lasserson, Daniel, Reeve, Joanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429627/ https://www.ncbi.nlm.nih.gov/pubmed/36042454 http://dx.doi.org/10.1186/s12916-022-02475-1

Ejemplares similares

Correction: Optimising a person-centred approach to stopping medicines in older people with multimorbidity and polypharmacy using the DExTruS framework: a realist review
por: Turk, Amadea, et al.
Publicado: (2022)

DeXtrusion: automatic recognition of epithelial cell extrusion through machine learning in vivo
por: Villars, Alexis, et al.
Publicado: (2023)

Foreword to the first special collection: Addressing the invisible iatrogenic epidemic: the role of deprescribing in polypharmacy and inappropriate medication use
por: Mangin, Dee, et al.
Publicado: (2019)

Multimorbidity or polypharmacy: two sides of the same coin?
por: Sinnott, Carol, et al.
Publicado: (2015)

Multimorbidity, polypharmacy, and mortality in older patients with pacemakers
por: Goto, Toshihiko, et al.
Publicado: (2021)

Italian guidelines on management of persons with multimorbidity and polypharmacy
por: Onder, Graziano, et al.
Publicado: (2022)

Evidence-Based Decision Support for a Structured Care Program on Polypharmacy in Multimorbidity: A Guideline Upgrade Based on a Realist Synthesis
por: Dinh, Truc Sophia, et al.
Publicado: (2022)

Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities
por: Ailabouni, Nagham, et al.
Publicado: (2017)

Demand for TRU nuclide cross-sections from the view point of TRU production and radiotoxicity
por: Kimura, R, et al.
Publicado: (2019)

Multimorbidity and polypharmacy: a risk factor for older patients
por: Cucinotta, Domenico
Publicado: (2022)

Optimising prescribing in older adults with multimorbidity and polypharmacy in primary care (OPTICA): cluster randomised clinical trial
por: Jungo, Katharina Tabea, et al.
Publicado: (2023)

DEX, Delirium and Dilemma
por: Magoon, Rohan, et al.
Publicado: (2023)

Social Prescribing in National Health Service Primary Care: What Are the Ethical Considerations?
por: BROWN, REBECCA C.H., et al.
Publicado: (2021)

Polypharmacy in multimorbid older adults: protocol for a systematic review
por: Sirois, Caroline, et al.
Publicado: (2017)

Theoretical Underpinnings of a Model to Reduce Polypharmacy and Its Negative Health Effects: Introducing the Team Approach to Polypharmacy Evaluation and Reduction (TAPER)
por: Mangin, Dee, et al.
Publicado: (2023)

Tailoring cultural offers to meet the needs of older people during uncertain times: a rapid realist review
por: Tierney, Stephanie, et al.
Publicado: (2022)

Optimising the accuracy of blood pressure monitoring in chronic kidney disease: the utility of BpTRU
por: Brothwell, Shona, et al.
Publicado: (2013)

What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey
por: Rozsnyai, Zsofia, et al.
Publicado: (2020)

Changes in prescribed medicines in older patients with multimorbidity and polypharmacy in general practice
por: von Buedingen, Fiona, et al.
Publicado: (2018)

Trends in multimorbidity and polypharmacy in the Flemish-Belgian population between 2000 and 2015
por: van den Akker, Marjan, et al.
Publicado: (2019)

Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management
por: Patel, Preya Janubhai, et al.
Publicado: (2017)

Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
por: McQueenie, Ross, et al.
Publicado: (2020)

Polypharmacy Patterns in Multimorbid Older People with Cardiovascular Disease: Longitudinal Study
por: Villén, Noemí, et al.
Publicado: (2022)

Multimorbidity and polypharmacy in hospitalized older patients: a cross-sectional study
por: Zhao, Yong, et al.
Publicado: (2023)

Understanding and Improving Older People’s Well-Being through Social Prescribing Involving the Cultural Sector: Interviews from a Realist Evaluation
por: Gorenberg, Jordan, et al.
Publicado: (2023)

Baseline characteristics and comparability of older multimorbid patients with polypharmacy and general practitioners participating in a randomized controlled primary care trial
por: Jungo, Katharina Tabea, et al.
Publicado: (2021)

Identifying enablers and barriers to individually tailored prescribing: a survey of healthcare professionals in the UK
por: Reeve, Joanne, et al.
Publicado: (2018)

Making patient values visible in healthcare: a systematic review of tools to assess patient treatment priorities and preferences in the context of multimorbidity
por: Mangin, Dee, et al.
Publicado: (2016)

Polypharmacy and medication deprescribing: A survey among multimorbid older adults in Denmark
por: Schiøtz, Michaela L., et al.
Publicado: (2018)

Longitudinal data of multimorbidity and polypharmacy in older adults in Taiwan from 2000 to 2013
por: Lai, Shih-Wei, et al.
Publicado: (2020)

Impact of Multimorbidity and Polypharmacy on Clinical Outcomes of Elderly Chinese Patients with Atrial Fibrillation
por: Kotalczyk, Agnieszka, et al.
Publicado: (2022)

Correction: Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort
por: McQueenie, Ross, et al.
Publicado: (2021)

Synergistic Effect of Perineural Dexamethasone and Dexmedetomidine (Dex-Dex) Prolong Analgesic Effect of a Preoperative Interscalene Block
por: Noor, Nazir A, et al.
Publicado: (2020)

International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action
por: Mangin, Dee, et al.
Publicado: (2018)

Multimorbidity, eHealth and implications for equity: a cross-sectional survey of patient perspectives on eHealth
por: Mangin, Dee, et al.
Publicado: (2019)

Transuranic (TRU) Waste Phase I Retrieval Plan
por: McDonald, K M
Publicado: (2000)

TruCCOMS: real-time continuous cardiac output?
por: Lichtenthal, PR, et al.
Publicado: (2008)

Synergistic Effect of Perineural Dexamethasone and Dexmedetomidine (Dex-Dex) in Extending the Analgesic Duration of Pectoral Type I and II Blocks
por: Zusman, Robert P, et al.
Publicado: (2020)

Correction: Synergistic Effect of Perineural Dexamethasone and Dexmedetomidine (Dex-Dex) Prolong Analgesic Effect of a Preoperative Interscalene Block
por: Noor, Nazir A, et al.
Publicado: (2020)

Relation of the pdxB-usg-truA-dedA Operon and the truA Gene to the Intracellular Survival of Salmonella enterica Serovar Typhimurium
por: Yang, Xiaowen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9q4pe5tdl0pack6gagcpf5civi